Funder: Ionis Pharmaceuticals
Due Dates: June 15, 2026 (Full application deadline) | September 14, 2026 (Acceptance deadline)
Funding Amounts: $50,000 per year; renewable for a second year (up to $100,000 total)
Summary: Supports early-career researchers conducting innovative research on severe hypertriglyceridemia and its impact on cardiovascular and metabolic diseases.
Key Information: For residents, fellows, or junior faculty within 3 years of postdoc; U.S. citizens, permanent residents, or select visa holders only.